Funding Received
$14 Million in 2 Rounds from 3 Investors
Most Recent Funding
$8.6 Million on July 25, 2011 / Undisclosed Round
Headquarters:
Köln
Description:
CEVEC Pharmaceuticals develops therapeutic proteins and monoclonal antibodies with human glycosylation patterns.
Categories:
Biotechnology
Website:
http://www.cevec.com

Company Details

Update

CEVEC Pharmaceuticals GmbH, a biopharmaceutical company, engages in developing and producing therapeutic proteins and monoclonal antibodies with human glycosylation patterns. The company was founded in 2001 and is based in Cologne, Germany.

Current Team (4)

Update

Funding Rounds (2) - $8.6M

Update

Investors (3)

Update

Offices/Locations (1)

Update
  • Office

    Gottfried-Hagen-Str. 62

    Köln, D-51105

    DEU